Diabetic foot is a serious, common condition that affects about half of those with diabetes. Key symptoms of diabetic foot include tingling and numbness in the feet, calluses, and peeling skin.

New research examining patients with healed diabetic foot ulcers revealed that daily foot temperature monitoring can result in lower rates of hospitalization and foot ulcer recurrence in high-risk ...

Researchers confirm that neuropathy and ischaemia are two main factors that result in diabetic foot ulcer with significant impairment of quality of life. Diabetic Foot Ulcers (DFU) are a common ...

SAN ANTONIO – San Antonio has earned a troubling distinction as the diabetic foot amputation capital of the world. This ...

In India, out of 62 million people with diabetes, 25% develop diabetic foot ulcers (DFUs). Of these, 50% become infected and ...

Amputation in type 1 diabetes is becoming relatively less common in Sweden. The rate has fallen by just over 40 percent over an approximately 20-year period, a University of Gothenburg study shows.

The FDA has removed from the prescribing information for the SGLT2 inhibitor canagliflozin a caution about increased leg and foot amputations among adults with type 2 diabetes taking the drug, ...

The FDA concluded “the risk no longer meets the standard for a Boxed Warning." The Food and Drug Administration (FDA) has issued a drug safety communication announcing the removal of the Boxed Warning ...

The FDA will remove the Boxed Warning or Black Box Warning about increased leg and foot amputation risk from the packaging of type 2 diabetes drug canagliflozin. In explaining the change, the agency ...